'Life is a marathon, not a sprint,' says Tata Sons’ Chandra

AI Quick Summary

Gold's price outlook is positive, with buying opportunities identified around Rs 1,53,650.

Key points

• Gold's intraday outlook is positive according to analysts.
• Current price is around Rs 1,53,870 after a recovery.
• Buy zone identified at Rs 1,53,650 with a stop-loss below Rs 1,52,900.
• Target price set at Rs 1,54,600.
• MACD indicates strong upward momentum.

AI Quick Summary

Higher income and credit scores improve loan approval chances, but lenders also consider existing debts and income stability.

Key points

• Higher income improves borrowing capacity but does not guarantee loan approval.
• Lenders assess income stability, employer profile, and existing financial commitments.
• Existing debt affects loan approval chances through the Fixed Obligation to Income Ratio (FOIR).
• Salaried borrowers are preferred due to predictable income patterns.
• Self-employed individuals face more scrutiny due to variable income.

AI Quick Summary

Ganesh Dongre recommends PN Gadgil Jewellers, Mankind Pharma, and BEML as top stocks to buy today.

Key points

• PN Gadgil Jewellers: Buy at Rs 600–620, Stop Loss: Rs 580, Target: Rs 650, Rs 670.
• Mankind Pharma: Buy at Rs 2250-2280, Stop Loss: Rs 2200, Target: Rs 3380, Rs 2450.
• BEML: Buy at Rs 2060-2080, Stop Loss: Rs 2020, Target: Rs 2280, Rs 2350.

AI Quick Summary

Motilal Oswal recommends Emcure and Cholamandalam as top stocks for the week starting September 18, 2026.

Key points

• Emcure Pharmaceuticals shows strong growth with a 22.8% YoY revenue increase in Q1FY27.
• Cholamandalam Investment is diversifying from vehicle finance to a broader lending platform.
• Management expects continued revenue growth and margin expansion for both companies.